Dr. Paul Sax questions the validity of a new Cochrane review on tenofovir + FTC + efavirenz in his blog
HIV and ID Observations.
Trial after trial has shown tenofovir + FTC + efavirenz to be a safe and effective regimen for first-line HIV treatment. Yet the authors of a new Cochrane review cite only one such trial and then conclude that more data are needed. Dr. Paul Sax sets the record straight in his blog HIV and ID Observations.